Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00235118 · ClinicalTrials.gov registry record · Phase 1

Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)

A Phase 1 study of Abdominal Aortic Aneurysm, sponsored by Cordis US.

Completed
Registry status
Phase 1
Development phase
29
Enrollment target
1
Study location

NCT00235118 is a Phase 1 study of Abdominal Aortic Aneurysm that has completed, run by Cordis US. The registered enrollment target is 29 participants, below the 452-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00235118, a Phase 1 study of Abdominal Aortic Aneurysm, has completed, sponsored by Cordis US.

COMPLETED
Registry status
Phase 1
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdominal Aortic Aneurysm (AAA).

Conditions Studied

Interventions

  • DEVICE Cordis AAA Bilateral Device

Study Locations (1)

New York

  • Mt. Sinai Hospital - New York

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 1999-12
Est. Completion 2006-02
Phase Phase 1

Sponsor

Cordis US

19 total trials

What the Registry Record Tells You About NCT00235118

The ClinicalTrials.gov registry entry for NCT00235118 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 452-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (94% lower). The listed sponsor is Cordis US, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Cordis AAA Bilateral Device is the first listed.

NCT00235118 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00235118 about?

NCT00235118 is a clinical study titled "Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)". The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdominal Aortic Aneurysm (AAA).

What is the current status of trial NCT00235118?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 1999-12. Estimated completion is 2006-02.

What conditions does trial NCT00235118 study?

This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.

What interventions are being tested in trial NCT00235118?

The interventions under investigation include: Cordis AAA Bilateral Device (DEVICE).

Who is sponsoring clinical trial NCT00235118?

This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00235118 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.